Correlation of serum protein and lipid profile with OSMF severity among the rural population of Southern India

Article Sidebar

pdf
Published: Apr 17, 2023
Keywords:
Protein, lipid profile, clinical staging, oral submucous fibrosis

Main Article Content

Kopparesh Rao Deshpande
Sri Sai College of Dental Surgery, Kothrepally, opp. Shiv Sagar Lake, Vikarabad, Telangana, India.
Swarup Kumar Panda
Department of Biochemistry, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Kalinga Nagar, Bhubaneswar, Odisha, India.
https://orcid.org/0000-0002-5866-0373
Itishri Jena
Department of Biochemistry, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Kalinga Nagar, Bhubaneswar, Odisha, India.
https://orcid.org/0009-0004-5363-6085
Sangeeta Sanghamitra Bhanja
Department of Biochemistry, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Kalinga Nagar, Bhubaneswar, Odisha, India.
Sarthak Ranjan Nayak
Department of Biochemistry, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Kalinga Nagar, Bhubaneswar, Odisha, India.
https://orcid.org/0000-0001-6975-9136
Subhashree Ray
Department of Biochemistry, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be) University, Kalinga Nagar, Bhubaneswar, Odisha, India.

Abstract

Background: Carcinogenesis is mostly observed due to alterations in serum protein and lipid levels.


Objectives: In this present study, serum protein and lipid profile are to be evaluated in OSMF patients and compared with various clinical stages of OSMF.


Materials and methods: Out of 100 study subjects, 45 OSMF patients were selected as cases; 55 apparently healthy individuals were chosen as controls. The level of serum total protein, albumin, and globulin; high density lipoprotein (HDL), very low density lipoprotein (VLDL), total cholesterol (TC), triglycerides (TG), and low density lipoprotein (LDL) were measured by COBAS-6000 autoanalyzer. The obtained data were processed with an independent sample t-test.


Results: Statistically significant reduction in serum total protein and albumin, LDL, HDL, TC, and TG levels were detected in all stages of OSMF patients in comparison with controls, whereas changes in serum VLDL level were not statistically significant.


Conclusion: The current study showed significant alterations in serum protein and lipid profile, with advancement in the clinical stages of OSMF. In the future, the alterations in these parameters might possess a diagnostic significance and can be utilized as a biochemical indicator for the detection of neoplastic processes like OSMF.

Article Details

How to Cite
Deshpande, K. R., Panda, S. K., Jena, I., Bhanja, . S. S., Nayak, S. R., & Ray, S. (2023). Correlation of serum protein and lipid profile with OSMF severity among the rural population of Southern India. Journal of Associated Medical Sciences, 56(2), 156–161. Retrieved from https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/258991
Issue
Vol. 56 No. 2 (2023): May-August
Section
Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Personal views expressed by the contributors in their articles are not necessarily those of the Journal of Associated Medical Sciences, Faculty of Associated Medical Sciences, Chiang Mai University.

References

Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis–a collagen metabolic disorder. J Oral Pathol Med. 2005; 34(6): 321-8. doi.org/10.1111/j.1600-0714.2005.00325.x

Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006; 42(6): 561-8. doi.org/10.1016/j.oraloncology.2005.08.005.

Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiology Biomarkers & Prevention. 2002; 11(7): 646-53. doi: pubmed.ncbi.nlm.nih.gov/12101112/

Bhuyan, R. ., Bhuyan, S. K., Panda, N. R. ., & Mohanty, J. (2022). Age and gender demographic and statistical analysis in oral squamous cell carcinoma in Eastern India. J Assoc Med Sc. 2023; 56(1): 35-9. doi: 10.12982/JAMS.2023.005.

Modi MA, Dave VR, Prajapati VG, Mehta KA. A clinical profile of oral submucous fibrosis. NJIRM 2012; 3(3): 152-5.

More CB, Gupta S, Joshi J, Varma SN. Classification system for oral submucous fibrosis. JIAOMR. 2012; 24(1): 24.

Gupta MK, Mhaske S, Ragavendra R. Oral submucous fibrosis: current concepts in etiopathogenesis. Indian Dermatol Online J. 2014; 5(3): 260-5. doi.org/10.4103/2229-5178.137772.

Kanthem RK, Guttikonda VR. Serum lipid profile in oral submucous fibrosis: A clinico pathological study. Journal of Oral and Maxillofacial Pathology: JOMFP. 2015 May; 19(2):139. [9]. Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol. 2009; 1: 10. doi.org/10.1186/1758-3284-1-10.

Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol. 2009; 1:1-10. doi.org/10.1186/1758-3284-1-10.

Sudarshan R, Annigeri RG. Pathogenesis of oral submucous fibrosis: The past and current concepts. J Oral Maxillofac Pathol. 2012 Apr 1; 3(2): 27-37. doi.org/10.1186/1758-3284-1-10.

Chandran V, Anitha M, Avinash SS, Rao GM, Shetty BV, Sudha K. Protein oxidation: A potential cause of hypoalbuminemia in oral cancer. Biomed Res. 2012; 23(2): 227-30.

Abhishek SN, Mubeen K, Vijayalakshmi KR, Suman B, Gayitri HC, Anitha M. Serum total protein, albumin and advanced oxidation protein products (AOPP)-implications in oral squamous cell carcinoma. Malays. J. Pathol. 2012; 34(1): 47-52.

Singh P, Gharote H, Nair P, Hegde K, Saawarn N, Guruprasad R. Evaluation of cachexia in oral submucous fibrosis. JIAOMR. 2012; 24(2): 130-2. doi: 10.5005/jp-journals-10011-1277.

Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signaling. Curr. Med. Chem. 2004; 11(9): 1163-82. doi.org/10.2174/0929867043365323.

Patidar KA, Parwani RN, Wanjari SP. Correlation of salivary and serum IgG, IgA levels with total protein in oral submucous fibrosis. J Oral Sci. 2011; 53(1): 97-102. doi.org/10.2334/josnusd.53.97.

Westra WH, Lewis JS. Update from the 4th edition of the World Health Organization classification of head and neck tumours: oropharynx. Head Neck Pathol. 2017; 11: 41-7. doi.org/10.1007/ s12105-017-0793-2 PMID: 28247229.

Dawood RM, Hasan HR. Assessment of salivary and serum proteins in patients with oral tumors. Baghdad Sci J. 2013; 10(03): 934-44. doi.org/10.21123/bsj.2013.10.3.934-944.

Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, Patel JB, Patel DD. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer. 2004; 41(1): 25-31.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015; 136(5): E359-86. doi.org/10.1002/ijc.29210 PMID: 25220842.

Allampallam K, Dutt D, Nair C, Shetty V, Mundle S, Lisak L, Andrews C, Ahmed B, Mazzone L, Zorat F, Borok R. The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes. J Cancer Stem Cell Res. 2000; 9(2): 247-55. doi.org/10.1089/152581600319469.

Ernani V, Saba NF. Oral cavity cancer: risk factors, pathology, and management. Oncology. 2015; 89(4): 187-95. doi.org/10.1159/000398801 PMID: 26088938.

Shih YH, Wang TH, Shieh TM, Tseng YH. Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy. Int J Mol Sci. 2019; 20(12): 2940. doi: 10.3390/ijms20122940. PMID: 31208114; PMCID: PMC6627879.

Chang YC, Tsai CH, Lai YL, Yu CC, Chi WY, Li JJ, Chang WW. Arecoline‐induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB 1. J Cell Mol Med. 2014; 18(4): 698-708. PMID: 24400868, PMCID: PMC4000120 doi: 10.1111/jcmm.12219.

Dubal M, Nayak A, Suragimath A, Sande A, Kandagal S. Analysis of smoking habits in patients with varying grades of smoker's palate in South Western region of Maharashtra. J Oral Res Rev. 2015; 7(1): 12. doi: 10.4103/2249-4987.160171.

Xu H, Lyu FY, Song JY, Xu YM, Jiang EH, Shang ZJ, Chen LL, Xu Z. Research achievements of oral submucous fibrosis: progress and prospect. Biomed Res Int. 2021; Article ID 6631856, 10 pages https://doi.org/10.1155/2021/6631856.

Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies. J Maxillofac Surg. 2017; 8(2): 89-94. doi: 10.4103/njms.NJMS_32_17.